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Abstract.  The GLUT4 glucose transporter appears to 
be targeted to a unique insulin-sensitive  intracellular 
membrane compartment in fat and muscle cells. Insu- 
lin stimulates glucose transport in these cell types by 
mediating the partial  redistribution of GLUT4 from 
this intracellular  compartment to the plasma mem- 
brane.  The structural basis for the unique targeting be- 
havior of GLUT4 was investigated in the insulin- 
sensitive L6 myoblast cell line.  Analysis of 
immunogold-labeled cells of independent clonal lines 
by electron microscopy indicated that 51-53 % of 
GLUT1 was present in the plasma membrane in the 
basal state. Insulin did not significantly affect this dis- 
tribution.  In contrast,  only 4.2-6.1%  of GLUT4 was 
present in the plasma membrane of basal L6 cells and 
insulin increased this percentage by 3.7-6.1-fold.  Under 
basal conditions and after insulin treatment,  GLUT4 
was detected in tubulovesicular structures,  often 
clustered near Golgi stacks,  and in endosome-like 
vesicles. Analysis of 25 chimeric transporters consist- 
ing of reciprocal domains of GLUT1 and GLUT4 by 
confocal immunofluorescence microscopy indicated 
that only the final  25 amino acids of the COOH- 
terminal  cytoplasmic tail of GLUT4 were both neces- 
sary and  sufficient for the targeting pattern observed 
for GLUT4. A  dileucine motif present in the COOH- 
terminal tail of GLUT4 was found to be necessary, 
but not sufficient, for intracellular targeting.  Contrary 
to previous studies, the NH2 terminus  of GLUT4 did 
not affect the subcellular distribution of chimeras. 
Analysis of a chimera containing the COOH-terminal 
tail of GLUT4 by immunogold electron microscopy in- 
dicated that its  subcellular distribution in basal cells 
was very similar to that of wild-type GLUT4 and that 
its content in the plasma membrane increased 
6.8-10.5-fold in the presence of insulin.  Furthermore, 
only the chimera containing the COOH terminus of 
GLUT4 enhanced insulin responsive 2-deoxyglucose 
uptake.  GLUTI and two other chimeras lacking the 
COOH terminus of GLUT4 were studied by im- 
munogold electron microscopy and did not demon- 
strate insulin-mediated  changes in subcellular distribu- 
tion.  The NH2-terminal cytoplasmic tail of GLUT4 
did not confer intracellular  sequestration and did not 
cause altered  subcellular distribution in the presence 
of insulin.  Intracellular  targeting of one chimera to 
non-insulin-sensitive  compartments was also observed. 
We conclude that the COOH terminus  of GLUT4 is 
both necessary and sufficient to confer insulin-sensi- 
tive subcellular targeting of chimeric glucose trans- 
porters in L6 myoblasts. 
LUCOS~ transport  into  cells  is  facilitated  by  the 
family of glucose transporter isoforms  (Bell et al., 
1990; Mueckler,  1994; Gould and Holman,  1993). 
GLUT4, expressed only in fat and muscle, is responsible for 
the increase in glucose uptake in these tissues in the presence 
of insulin.  This is caused by its translocation  from an intra- 
cellular compartment to the plasma membrane in response 
to insulin.  In contrast to GLUT1,  which is present in the 
plasma membrane as well as in intracellular  compartments 
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and therefore  contributes to basal glucose uptake,  GLUT4 
is virtually excluded from the plasma membrane in the ab- 
sence of insulin.  Insulin  causes a small  enrichment  in the 
GLUT1 content of the adipocyte plasma membrane (Piper et 
al., 1991), on the order of that observed in response to insu- 
lin or insulin-like growth factors, for several membrane pro- 
teins,  such  as  the  ~-2  and ~-1  subunits  of the  Na  ÷,  K ÷- 
ATPase  (Hundal  et  al.,  1992),  the  IGF-U/mannose-6- 
phosphate receptor (Damke et al., 1992), and the transferrin 
receptor (Damke et al.,  1992).  However, insulin  does not 
change the distribution  of either GLUT1 or Na÷-K÷-ATPase 
o~-1 subunits in plasma membranes of red or white muscles 
(Marette et al.,  1992b). In contrast,  in response to insulin, 
GLUT4 is enriched  in the plasma membrane, and glucose 
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(Smith and Lawrence, 1984; Marette et al., 1992a,b; Wilson 
and Cushman, 1994) and up to 30-fold in fat (Holman et al., 
1990).  The distinctive subcellular distributions of GLUT1 
and GLUT4 are reflected in the differential effects of overex- 
pression of these transporters on glucose transport activity. 
Overexpression of GLUT1 in a variety of systems, including 
3T3-L1 fibroblasts (Haney et al.,  1991), CHO cells (Asano 
et al., 1992), Xenopus oocytes (Marshall et al., 1993a), L6 
myoblasts (Robinson et al.,  1993),  and transgenic mouse 
muscle (Marshall et al., 1993b), increases basal glucose up- 
take but does not enhance insulin responsiveness. In con- 
trast, overexpression of GLUT4 in insulin-sensitive L6 myo- 
blasts increases insulin-responsive glucose uptake without 
significantly affecting basal uptake (Robinson et al., 1993). 
The two transporters exhibit differential targeting despite the 
level of identity (65 %) and similarity (76%) in amino acid 
sequence they share. We set out to identify the structural ba- 
sis  for  the  unique  intracellular  targeting  of GLUT4  in 
insulin-sensitive cells by studying the expression of chimeric 
glucose transporters composed of complementary regions of 
GLUT1 and GLUT4. 
Several earlier studies indicated that GLUT4 targeting is 
isoform-specific and independent of cell type (Haney et al., 
1991; Hudson et al., 1992; Shibaski et al., 1992; Kotliar and 
Pilch,  1992).  This observation led to the use of insulin- 
insensitive cells to delineate domains of GLUT4 that cause 
intracellular sequestration.  Five different groups have  re- 
ported three different and mutually contradictory sets  of 
results derived from targeting of chimeric glucose trans- 
porters. Piper et al. (1992) used Sindbis virus to overexpress 
chimeras  in  CHO  cells and concluded that the  NH2-ter- 
minus of GLUT4 confers intracellular sequestration. Asano 
et al. (1992) used stable transfection of CHO cells and con- 
cluded that regions in the first and third quarters of GLUT4, 
but neither its NH2 terminus nor its COOH terminus, con- 
tain intracellular targeting signals. Marshall et al. (1993a) 
demonstrated that in Xenopus oocytes, the COOH terminus 
conferred sequestration of fully glycosylated chimeras in a 
low-density intracellular membrane compartment. The re- 
gion between amino acids 24 and 132 of GLUT4 contributed 
to sequestration, but this was attributed at least in part to an 
altered rate of processing. Czech et al. (1993) demonstrated 
by transient transfection of COS-7 cells and stable transfec- 
tion of CHO cells, and Verhey et al. (1993) demonstrated by 
stable  transfection of NIH  3T3  and  PC12  cells,  that the 
COOH terminus of GLUT4 confers intracellular targeting. 
These studies also indicated a less important signal between 
amino acids 53  and  199  (Czech et al.,  1993) or between 
amino acids  1 and  183  (Verhey  et al.,  1993)  of GLUT4. 
Verhey and Birnbaum (1994) recently identified a dileucine 
motif of the COOH terminus as necessary for intracellular 
targeting of GLUT4. Corvera et al. (1994) have recently pre- 
sented evidence that the dileucine motif  operates as an endo- 
cytic signal. Thus, a consensus is emerging that the COOH 
terminus of GLUT4 is important for intracellular targeting. 
However,  since these studies were carried out in cells that 
do not respond to insulin, they all include the assumption 
that intraceUular accumulation of a chimeric transporter in 
insulin-insensitive cells accurately reflects targeting to the 
native insulin-sensitive intracellular compartment of a fat or 
muscle cell. A recent study suggests the tenuous nature of 
this assumption by showing that chimeras comprised of do- 
mains of dipeptidyl peptidase IV  and aminopeptidase N, 
both of which normally target to the plasma membrane, ap- 
peared to target to the trans-Golgi network (Low et al., 
1994). This aberrant result was attributed to inefficient  trans- 
port from the Golgi to the cell surface. 
We considered it important for our studies of specific tar- 
geting domains of chimeric glucose transporters to deter- 
mine the subcellular distribution at steady state in insulin- 
sensitive cells that are expressing little or no GLUT4 and are 
expressing exogenous glucose transporters at approximately 
the level at which glucose transporters are naturally abun- 
dant.  These considerations take into account phenomena 
that might cause misleading results, such as dimerization of 
chimeras with endogenous GLUT4 and saturation of specific 
sorting systems. The study reported here was thus carried 
out in L6 myoblasts. Upon spontaneous differentiation into 
myotubes, these cells express GLUT4 and become insulin 
sensitive; however, maintained as myoblasts in 10% serum, 
differentiation is inhibited and very little GLUT4 is expressed 
(Mitsumoto et al., 1992). Lawrence et ai. (1992) showed that 
expression of exogenous GLUT4 at the myoblast stage con- 
fers insulin responsiveness, and subsequently confirmed this 
in three additional clonal lines of L6 cells overexpressing 
GLUT4 (Robinson et al., 1993). Thus, these cells appear to 
contain all of the machinery necessary for insulin-sensitive 
trafficking of GLUT4, and to exhibit differential targeting 
and insulin-responsiveness  of  transfected GLUT1 and GLUT4 
(Robinson et al., 1993). We therefore reasoned that L6 myo- 
blasts might represent a suitable system to define the region(s) 
of GLUT4 important in targeting to an insulin-sensitive in- 
tracellular compartment. In doing so, we show that targeting 
of chimeric glucose transporters to non-insulin-sensitive in- 
tracellular compartments can occur. Our results show that 
insulin-sensitive targeting  of GLUT4  is  conferred by  its 
COOH-terminal cytoplasmic tail. We also present evidence 
that the dileucine motif  within the COOH-terminal cytoplas- 
mic tail is necessary, but not sufficient, for insulin-sensitive 
targeting.  We find no role for the NH2-terminal cytoplasmic 
tail of GLUT4. 
Materials and Methods 
Cell Culture and 2-Deoxyglucose 
Uptake Measurements 
L6 myoblasts (American Type Culture Collection, Rockville, MD) were 
grown in alpha-minimal essential medium supplemented with  10%  FCS 
(Robinson et al., 1993), 50 U/ml penicillin, 50 #g/ml streptomycin, and 250 
ng/ml amphotericin B in an atmosphere of 5% CO2 at 37°C. All experi- 
ments were performed on the day  before confluence would have been 
attained, before any sign of differentiation. Medium was changed one day 
before experiments. [3H]-2-Deoxyglucose uptake was measured as previ- 
ously described (Tordjman et al., 1989). Non-carder-mediated uptake was 
measured in the presence of 20 ~M cytochalasin B. Cells were incubated 
in serum-free medium for 2 h before measurement. Insulin-stimulated up- 
take was measured after 20-min incubation with 10  -6 M insulin (Robinson 
et al.,  1993) in serum-free medium. Protein content was measured by the 
bicinchoninic acid assay (Pierce Chemical Co., Rockford, IL). 
Construction of Glucose Transporter 
Expression Vectors 
Chimeric glucose transporter cDNAs were prepared using recombinant 
PCR (Vallette et al., 1989).  The amino acids were numbered according to 
previously published sequences (Mueckler et al., 1985;  Birnbaum, 1989; 
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et ai.,  1989). Chimeras consisted partially of human GLUT1 and partially 
of rat GLUT4 and were constructed by engineering junctions at analogous 
points in the two transporters. The nomenclature for chimeras denotes the 
composition of the chimera beginning at the NH2 terminus. Thus, a "14" 
chimera begins with GLUT1 and ends with GLUT4; a "141' chimera begins 
and ends with GLUTI but contains GLUT4 within it. The number(s) fol- 
lowing the initial designation indicate the amino acid number, according to 
the transporter contributing the NH2 terminus, of the junction(s). Thus, 
the chimera 14-450 contains the first 450 amino acids of GLUTI, and the 
remainder is GLUT4. The converse chimera, at the same junction, was 
denoted as 41-466 because it contains the first 466 amino acids of GLUT4, 
but the rest is GLUTI. Three-part chimeras are also numbered according 
to the transporter contributing the NH2 terminus, so that, for example, the 
chimera 141-450,464 contains the first 450 amino acids of GLUTI, then the 
corresponding next 13 amino acids of GLUT4, then resumes with amino 
acid 464 of GLUT1. Fig. 1 illustrates the twelve  junctions used in construc- 
tion of the chimeras. Junction H was used for chimeras 14-450 and 41-466, 
while  junctions H and I were used for chimera 141-450, 464. The first round 
of PCR was carried out using GLUT1 or GLUT4 eDNA as appropriate,  as 
template.  In most cases,  GLUT4 eDNA had been previously  altered by 
recombinant  PCR to introduce, in a reciprocal fashion, the analogous region 
of the intracellular  loop amino acids 233-246 of human GLUT1, which con- 
tains the epitopo for the species-specific monoclonal antibody 37.6. One oli- 
gonueleotide primer consisted of 15 nucleofides on each side of the chosen 
junction; the second oligonucleotide  was the appropriate 5'or 3'primer con- 
venienfly designed to include restriction enzyme sites to facilitate subclon- 
ing. Full-langth chimeric cDNAs produced by the recombinant PCR reac- 
tion were then subcloned into the mammalian expression  vector Rc/CMV 
(Invitrogen,  San Diego, CA), which contains the neomycin resistance gene. 
Several constructs, including  14-450, were completely  sequenced to con- 
finn the fidelity of PCR. Site-directed  mutagenesis  was carried out accord- 
ing to established protocols (Clonteeh, Palo Alto, CA). The mutations in- 
troduced  into the chimera 14-450 to create the chimera 14-450 (IA89., 
L490S)  are in the dileucine motif located  at amino acids 489 and 490 of 
GLUT4. 
Transfection of  Maramalian Cell  Lines 
Confluem I.,6 myoblasts were split 1:5 into 10-cm dishes 24 h before trans- 
fection with a calcium phosphate precipitate containing 25 #g of recom- 
binant pRc/CMV, as described previously  (Haney et al.,  1991). Cells were 
exposed  to 0.8 mg/ml G418 (active  fraction 0.51 mg/ml) (GIBCO BRL, 
Gaithersburg,  MD) during selection and were subsequently  maintained in 
medium containing 0.4 mg/ml G418  to limit growth  of revertants.  Con- 
structs  intended for 2-deoxyglucose  uptake experiments  and electron mi- 
croscopy  were  used to generate cloned cell lines.  Approximately  100 in- 
dividual G418-resistant colonies were isolated with cloning tings after 2 wk 
of selection,  grown to confluence in 24-well tissue culture dishes, screened 
by Western blotting,  and selected  colonies were then grown in mass.  All 
selected clonal cell lines expressed exogenous transporters at levels less than 
or approximately the same as the levels of endogenous glucose transporters. 
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Figure 1.  Junctions used in the construction of GLUT1-GLUT4 chimeras. The postulated topology and amino acid sequence of GLUT4 
are shown (James et al.,  1989). Amino acid residues that are identical in GLUTI and GLUT4 are circled.  The two transporters are 65% 
identical in sequence. The twelve  junctions used in the construction of the 25 chimeric glucose transporters reported here are labeled (A-L). 
Also shown for GLUT1 and GLUT4 is the number of amino acids in each transporter from the NH2 terminus to each junction. For exam- 
ple, GLUTI has 450 amino acids NH2-terminal to junction H, while GLUT4 has 466 amino acids NH2-terminal to junction H. Therefore, 
the converse chimeras at this junction are named  14-450 and 41-466 (see text). 
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at levels higher than the range of levels of endogenous transporters. Most 
constructs intended for analysis only by confocal microscopy  were studied 
as pooled permanent transfectants;  rather than isolating individual clones, 
G418-resistant cells were trypsinized after 10 d of selection and grown on 
coverslips for study. Only a small fraction of pooled G418-resistant cells 
express exogenous glucose transporter. 
Western Blot Analysis and Confocal 
Immunofluorescence  Microscopy 
Transfected cell lines were characterized by SDS-PAGE and Western blot 
analysis, using rabbit polyclonal antisera to human GLUT1 (F350), mouse 
GLUT3  (mGLUT3),  and  rat  GLUT4  (F349),  as  described previously 
(Harley et al., 1991). In each case, the antigens for these sera were synthetic 
peptides corresponding to the final 16 amino acids of the COOH terminus, 
and each antibody is highly  specific. A species-specific  monoctonal anti- 
body to human GLUTI, 37.6, directed against an epitope including his-239 
of human GLUT1, within its intracellular loop, was a kind gift of Dr.  G. 
Lienhard (Dartmouth Medical  School),  (Allard and Lienhard, 1985).  Ex- 
cept for GLUT4 and the constructs 14-232 and 141-116, 272, all constructs 
contained the monoclonal  epitope. 
The quantities  of the glucose transporter proteins expressed  in trans- 
leered cell lines were determined by Western blot, with comparison to stan- 
dards consisting of purified human  erythrocyte glucose transporter to quan- 
titate GLUT1 or cytochalasin B-titered low density microsomes from rat 
adipocytes  to quantitate GLUT4, as described previously  (Honey  et al., 
1991).  For  GLUT3,  rat brain was  used as  a  standard,  and results are 
presented as GLUT3 content relative to untransfected L6 myoblasts. Signals 
were quantitated by densitometry. 
Confocal immunofluorescence  microscopy was carded out as previously 
described (Honey et al.,  1991), using COOH-terrninal peptide immuno- 
affinity purified  antibodies F350 and F349 (Parekh et al.,  1989) against 
GLUT1 and GLUT4, respectively. Protein A-purified monoclonal antibody 
37.6, directed against the human GLUT1  epitope contained in nearly all 
chimeras, was used for specific detection of exogenous transporters. 
Electron Microscopy 
Confluent  15-cm dishes of L6 myoblasts were rinsed three times with PBS 
and treated with 0.05 % trypsirdO.2 % EDTA. Trypsinlzed  cells were cen- 
trifuged  at  300 g  for  5  rain at 4°C  and fixed  with 2%  paraformalde- 
hyde/0.2 % g|utaraidehyde in PBS, pH 7.2, at room temperature for 2 h. This 
brief trypsin exposure did not affect the subcellnlar distribution of GLUTI 
or GLUT4  (data not shown).  Cells were embedded in  10%  gelatin as 
described by Slot and G-euze (1988) but without fixation of the gelatin.  Af- 
ter  pelleting  the  ceils,  the  gelatin  was  solidified  on  ice.  Blocks  for 
ultracryotomy were prepared and infused with 2.3 M sucrose for 2 d. Ultra- 
thin sections were prepared and imrnunolabeled  as described by Slot et al. 
(1991a) with the following modifications.  10% fetal bovine serum was used 
in the blocking buffer in place of 1% BSA. Immunolabeling with affinity- 
purified antibodies was carried out for 2 h. Incubation with secondary anti- 
bodies (Jackson  ImmunoResearch  Laboratories, West Grove,  PA) 18 nm 
goat anti-rabbit  IgG/Au for the rabbit  polyclonal antibodies F349 and F350, 
and 12 run goat anti-mouse IgG/Au for the mouse monoclonal antibody 
37.6, was carded out for 1 h. Sections were stained with uranyl acetate and 
embedded in methyl cellulose  according to a modification of the Tokuyasu 
method (Tokuyasu,  1980) introduced by Griffiths et al. (1984). Specimens 
were viewed and photographed using a Zeiss 902 electron microscope.  In- 
tact cells with adequate  morphology were selected for quantitation of im- 
munogold labeling.  Particles within 20 nm of the plasma membrane were 
defined as plasma membrane for purposes of quantitation (Slot and Oeuze, 
1988; Slot et al., 1991a). Particles within clusters were counted individu- 
ally. For each condition (basal vs. insulin) of each independent cell line, ten 
ceils were counted; these were from two to four grids of a single section 
from a single fixation. Up to three independent  cell lines per construct were 
studied. 
Results 
Rat L6 myoblasts were stably transfected with a plasmid en- 
coding both neomycin resistance and one of a series of wild- 
type and chimeric glucose transporters.  Cells resistant to 
G418 were studied either as pooled permanent transfectants 
Figure 2.  Expression  of wild-type  and  chimeric  glucose  trans- 
porters in L6 myoblast cell lines. Identical 20 t~g aliquots of total 
detergent-soluble protein fractions were electrophoresed on  10% 
polyacrylamide gels and the gels subjected to Western blotting as 
described in Materials and Methods. The first blot was incubated 
with F350, a polyclonal antibody that recognizes both endogenous 
GLUTI and chimeras containing the GLUT1 COOH terminus. The 
second blot was incubated with RaGLUT3m, which recognizes the 
COOH  terminus of GLUT3.  The third blot was  incubated with 
F349, which recognizes endogenous GLUT4 and chimeras contain- 
ing the GLUT4 COOH terminus. The final blot was incubated with 
37.6,  a species-specific monoclonal antibody that recognizes only 
exogenous transporters containing the appropriate epitope of the 
human  GLUT1  intracellular  loop,  which  was  engineered  into 
nearly all chimeras. Standards were: for F350, 30 ng of purified hu- 
man erythrocyte glucose transporter; for RaGLUT3m, 50 #g of rat 
brain detergent-soluble protein fraction; for F349,  a  cytochalasin 
B-titered rat LDM fraction containing 5 ng of GLUT4; and for 37.6, 
20 ng of purified human erythrocyte glucose transporter. 
or, if intended for more detailed study, clonal cell lines were 
isolated. Nearly all chimeric glucose transporters were de- 
signed to include the epitope for 37.6, a well characterized 
species-specific  monoclonal antibody against human GLUT1 
(Allard and Lienhard, 1985; Honey et al.,  1991; Verhey et 
al.,  1993).  Verhey et al. (1993) used this strategy to permit 
the use of a  single antibody to characterize chimeric glu- 
cose transporter targeting. This antibody, which was used in 
screening colonies by Western blotting, recognizes only ex- 
ogenous transporters. An additional advantage of using this 
antibody, which recognizes an epitope in the intraceUular 
loop between the sixth and seventh transmembrane domains 
of GLUT1, is that the COOH-terminal epitope recognized by 
the polyclonal antibody F349 has been suspected of being 
"masked" under certain conditions (Smith et al.,  1991). 
The  levels  of both endogenous and exogenous glucose 
transporters varied in clonal cell lines (Fig. 2). The F350 and 
F349 sera recognizes endogenous GLUTI and GLUT4, re- 
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respective  COOH-terminai  epitopes,  while  the  species- 
specific monoclonal antibody 37.6 recognizes only exoge- 
nous transporters containing histidine-239 of the intracellu- 
lar loop midway through the human transporter (Davies et 
al.,  1987),  between junctions D  and E  (see Fig.  1).  Den- 
sitometry revealed that the level of total GLUT1 expression 
in the transfected cell line was approximately 2.7-fold above 
the endogenous level, at slightly less than 0.1% of total pro- 
tein. GLUT4 was expressed at a level eightfold greater than 
that in untransfected cells, but constituted less than 0.01% of 
total protein. The highest level of expression of any exoge- 
nous transporter was about 0.1% of total protein. The level 
of endogenous GLUT3 expressed in the various transfected 
cell lines was variable. 
The targeting of GLUT1 and GLUT4 in lines overexpress- 
ing these transporters as revealed by laser confocal immu- 
nofluorescence microscopy is shown in Fig. 3. For GLUT1, 
staining is shown both for the polyclonal and for the spe- 
cies-specific monoclonal antibody. As in 3T3-L1 fibroblasts 
(Haney et al., 1991), GLUT4 was effectively excluded from 
the  plasma  membrane.  In  contrast,  there  was  abundant 
plasma membrane staining for GLUT1. GLUT4 was present 
in a discrete perinuclear compartment and was observed in 
a punctate pattern throughout the cytoplasm. It is evident 
from the low power views that GLUT1 also displayed intra- 
cellular staining, although not always in the focal plane of 
the laser. 
The strategy used to determine the intracellular targeting 
domains of GLUT4 was to initially use confocal immunoflu- 
orescence microscopy to examine the intracellular targeting 
activity of each half  and then each quarter of  the protein, and 
then to focus on areas of interest for further study.  Fig. 4 
shows the distribution of  41-222 (junction C), 41-248 and 14- 
232 (junction D), and 14-271 (junction E). Only the COOH- 
terminal half  of  GLUT4 conferred intracellular targeting and 
exclusion from the plasma membrane. The constructs con- 
taining the NH~-terminal  half of GLUT4 targeted similarly 
to wild-type GLUT1.  Fig. 4 also shows the distribution of 
41-132 (junction A),  141-116,272 (junctions B and E),  141- 
271,360 (junctions E and F), and 14-359 (junction F). These 
constructs each contain one of the four quarters of GLUT4 
in a GLUT1 backbone. Only the fourth quarter conferred in- 
tracellular targeting and exclusion from the plasma mem- 
brane.  The  constructs  containing  one  of the  first  three 
quarters targeted similarly to wild-type GLUT1. 
Within the fourth quarters  of GLUTI and GLUT4, the 
final three transmembrane domains are strikingly homol- 
ogous  (Fig.  1),  and  the  major  divergence  between  the 
two transporters is within the COOH-terminal cytoplasmic 
Figure 3. Confocal immunofluorescence  microscopy  of clonal lines of transfected  L6 myoblasts  expressing GLUT1 and GLUT4. Represen- 
tative lower and higher magnification  fields of untransfected  control cells and of clonal cell lines overexpressing GLUT1 and GLUT4 are 
shown. For GLUT1, results are shown for both the polyclonal antibody F350, which recognizes the COOH terminus of GLUTI, and the 
species-specific monoclonal antibody 37.6, which recognizes an epitope of the intracellular loop midway through the transporter. For 
GLUT4, results are shown for the polyclonal antibody F349, which recognizes the COOH terminus of GLUT4. (a-c) Polyclonal  antibody 
F350: (a) control, (b and c) GLUTI; (d-f) monoclonal antibody 37.6: (d) control, (e and f) GLUT1; (g-i) polyclonal antibody F349: 
(g) control, (h and i) GLUT4. Bars, 20 #m. 
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GLUT1 and half GLUT4 (upper panels), and of approximately  each quarter of GLUT4, with the remainder GLUTI (lower  panels). Shown 
in the upper panels are: 41-222 (junction C), 41-248 (junction D), 14-232 (junction D), and 14-271 (junction E). Shown in the lower panels 
are: 41-132 (junction B), 141-116,272 (junctions B and E), 141-271,360 (junctions  E and F), and 14-359 (junction F). Antibodies  include: 
F350,  which recognizes the COOH terminus of GLUT1; F349, which recognizes  the COOH terminus of GLUT4; and 37.6, the species- 
specific monoclonal antibody which recognizes an epitope of the GLUT1 intraceUular loop engineered  into most chimeras.  Clonal lines: 
41-248;  14-232;  14-271; and 41-132; pooled G418 resistant  cells: 41-222;  141-116,272; 141-271,360;  14-359. Bars,  20 #m. 
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which contains only the COOH-terminal cytoplasmic tail of 
GLUT4, using both the polyclonal antibody F349 and the 
monoclonal antibody 37.6. Targeting of this chimera, which 
contains only the final 43 amino acids of GLUT4, was indis- 
tinguishable from that of GLUT4 itself. Also shown in Fig. 
5 are 41-440  (junction G) and 41-466  (junction H), which 
were targeted to the plasma membrane, as expected. Finally, 
414-440,467  (junctions G and H), was sequestered within 
the cell. Taken together, these data show that the COOH- 
terminal cytoplasmic tall of GLUT4 is both necessary and 
sufficient to confer intracellular sequestration on chimeric 
transporters. 
To further localize the targeting information within the 
COOH terminus, a  series of constructs consisting of pro- 
gressively more  GLUTI  and less  GLUT4  was  designed. 
These include 14-463 (junction I), 14-468 (junction J),  14- 
473 (junction K), and 14-481 (junction L). Fig. 6 shows a 
striking difference between the intracellular targeting of 14- 
463 and 14-468, whose targeting was indistinguishable from 
GLUT4, and the targeting of 14-473 and 14-481, whose tar- 
geting resembled that of GLUT1. This difference is apparent 
both with the polyclonal  antibody to GLUT4 and the species- 
specific monoclonal antibody to  the  intracellular loop of 
GLUTI. This suggests that the six amino acids of GLUT4 
which  differ between the  constructs  14-468  and  14-473, 
RTPSLL, contain information that is necessary for the intra- 
cellular sequestration of GLUT4. 
Of note in the six amino acid sequence RTPSLL is a dileu- 
cine motif, which has been shown to be an essential compo- 
Figure 5. Confoeal immunofluorescence  microscopy of transfected  L6 myoblasts  expressing chimeras dissecting the intracellular targeting 
properties of the fourth quarter of GLUT4. Shown are: 14-450 (junction H), 41-440 (junction G), 41-466 (junction H), and 414-440,467 
(junctions G and H). Antibodies include: F350, which recognizes the COOH terminus of GLUT1; F349, which recognizes the COOH 
terminus of GLUT4; and 37.6, the species-specific monoclonal antibody which recognizes an epitope of the GLUT1 intracellular loop en- 
gineered into most chimeras. Clonal lines: 14-450 and 41-440; pooled G418-resistant cells: 41-466 and 414-440,467. Bars, 20/~m. 
Harley et al. Insulin-sensitive Targeting of GLUT4  647 Figure 6. Confocal immunofluorescence  microscopy of transfected  L6 myoblasts expressing chimeras containing mostly GLUT1 and pro- 
gressively smaller portions of  the COOH-terminal cytoplasmic tail of  GLUT4. Shown are: 14-463 (junction I), 14-468 (junction J), 14-473 
(junction K), and 14.481 (junction L). Antibodies  include:  F349, which recognizes the COOH terminus of GLUT4, and 37.6, the species- 
specific monoclonal antibody which recognizes an epitope of the GLUT1 intracellular  loop contained in these chimeras.  Clonal line:  14- 
468; pooled G418-resistant  cells:  14-463,  14-473, and  14-481. Bars,  20 ~m. 
The Journal of Cell Biology, Volume 129, 1995  648 Figure 7. Confocal immunofluorescence microscopy of transfected L6 myoblasts expressing chimeras designed to dissect the intracellular 
targeting activity of the COOH-terminal cytoplasmic tail of GLUT4. Shown are:  14-450 (L489; IA90S),  141-463, 474 (junctions I and 
K), 141-450, 464 (junctions H and I), and 141-463, 469 (junctions I and J). Cells were stained with 37.6, the species-specific monoelonal 
antibody which recognizes an epitope of  the GLUT1 intracellular loop contained in these chimeras. Shown are pooled G418-resistant cells. 
Bars, 20 #m. 
nent  of  certain  targeting  signals,  and  which  has  been 
reported to be important for GLUT4 targeting in insulin- 
insensitive cells (Verhey and Birnbaum, 1994). We designed 
the construct  14-450 (L489-,  L490S) to test whether the 
dileucines are essential to the targeting of GLUT4; the re- 
gion of GLUT1 analogous to the dileucine motif of GLUT4 
contains  only  a  single  serine  residue  (Birnbaum,  1989; 
Charron et al.,  1989; Fukumoto et al.,  1989; James et al., 
1989; Kaestner et al.,  1989). As shown in Fig. 7, mutation 
of the dileucine motif to the corresponding amino acid (.S) 
of GLUT1 had a striking effect on the targeting of 14-450; 
the mutant construct demonstrated abundant plasma mem- 
brane  staining.  Targeting  of the  construct  141-463,  474 
(junctions I and K), which exhibits a distribution similar to 
GLUT1,  showed  that  neither the  dileucine motif nor the 
six-amino acid sequence RTPSLL is sufficient to confer in- 
tracellular targeting, and that at least some of the amino acid 
residues beyond L490 of GLUT4 are required for intracellu- 
lar targeting. The constructs 141-450, 464 (junctions H and 
I) and 141-463, 469 (junctions I and J) showed a distribution 
similar  to  GLUTI,  confirming that the  first  18  of the 43 
amino acids of the COOH terminus are not sufficient to con- 
fer intracellular targeting. 
To verify that the final 25 amino acid residues of GLUT4 
are sufficient and the dileucine motif is essential for intracel- 
lular targeting,  the constructs 41-479  Gunction 1),  41-490 
(junction K) and 41-498 (junction L) were designed (Fig. 8). 
We predicted, based on the above results, that 41-479 and 41- 
490 would exhibit GLUTI-Iike targeting behavior, and that 
the targeting of 41-498 would depend on whether all of the 
remaining amino acids that are necessary to confer intracel- 
lular targeting lie between E491  and T498 of GLUT4. In 
contrast to our prediction, all three constructs demonstrated 
intracellular  targeting  (Fig.  8).  This  suggested  that  more 
than one mechanism might be involved in the intraceUular 
targeting of glucose transporter chimeras. We designed the 
chimera 414-440,491  (junctions G  and K) to analyze this 
further. This chimera lacks the dileucine motif and therefore 
would not be expected to confer intracellular targeting. The 
portions of it made up of GLUT4, the first 440 amino acids 
and the final 19 amino acids, were shown above to not cause 
intraceUular  targeting when tested independently, in chimeras 
41-440 and  14-473.  Paradoxically, as shown in Fig. 9, this 
chimera was retained within the cell and was excluded from 
the plasma membrane. It is demonstrated below that the in- 
tracellular accumulation of this chimera does not reflect tar- 
geting to an insulin-sensitive compartment. 
Because of previous  reports  that  the  NH2  terminus  of 
GLUT4  confers  intracellular  sequestration  (Piper  et  al., 
1992,  1993), we examined the targeting of 41-24 (junction 
A),  which contains the NH2 terminus of GLUT4 with the 
remainder of the molecule being GLUT1. Fig. 9 shows that 
Haney et al. Insulin-sensitive Targeting of GLUT4  649 Figure 8. Confocal immunofluorescence microscopy of transfected L6 myoblasts expressing chimeras containing mostly GLUT4 and pro- 
gressively smaller portions of the COOH-terminal cytoplasmic tail of GLUT1. Shown are: 41-479 (junction I), 41-490 (junction K), and 
41-498 (junction L). Antibodies include: F350, which recognizes the COOH terminus of GLUT1, and 37.6, the species-specific monoclonal 
antibody which recognizes an epitope of the GLUTI intracellular loop engineered into these chimeras. Shown are pooled G418-resistant 
cells. Bars, 20/~m. 
this  construct  exhibited  targeting  indistinguishable  from 
GLUT1. In contrast, 414-24,467 (junctions A and H), which 
contains the NH2 and COOH termini of GLUT4 flanking 
GLUT1 sequence, showed targeting indistinguishable from 
GLUT4. 
Our goal was to study chimeric glucose transporter target- 
ing in an insulin-responsive system. One method to evaluate 
insulin-responsive targeting is by quantitating transporters 
in partially purified fractions of  plasma membrane and intra- 
cellular  membranes.  We  carried  out  preliminary  experi- 
ments using published procedures but concluded, as have 
others (Lawrence et al., 1992), that these procedures did not 
result in a useful and reproducible degree of enrichment. At- 
tempts to demonstrate changes in the subcellular distribution 
of GLUT4 in response to insulin with confocal immunofluo- 
rescence microscopy were also unconvincing. We therefore 
examined whether immunogold labeling and electron mi- 
croscopy might be more sensitive for detection of transloca- 
tion. Slot et al. have shown the usefulness of this method for 
detection of GLUT4 translocation in brown adipose tissue 
The Journal of Cell Biology,  Volume 129, 1995  650 Figure 9. Confocal immunofluorescence microscopy of transfected 
L6 myoblasts. Shown  are: 414-440, 491, which contains two por- 
tions of GLUT4, the first 440 amino acids and the final 19 amino 
acids;  41-24 (junction A),  which contains the NH2 terminus of 
GLUT4; and 414-24, 467 (junctions A and H), which contains the 
NH~ and COOH termini of GLUT4. Cells were stained with 37.6, 
the species-specific monoclonal antibody which recognizes an epi- 
tope of the GLUT1 intracellular loop contained in these chimeras. 
Shown are clonal cell lines. Bars, 20/zm. 
(1991a)  and in cardiac myocytes (1991b).  GLUTI staining 
was abundant in the plasma membrane, especially in micro- 
villi (Fig.  10).  In contrast, GLUT4 labeling of the plasma 
membrane was minimal  and staining was concentrated in 
endosome-like vesicles and tubulovesicular structures, often 
in close proximity to Golgi stacks (Fig. 11). Thus, the distri- 
bution of GLUT4 in L6 myoblasts was very similar to that 
reported in brown fat (Slot et al.,  1991a),  skeletal muscle 
(Rodnick et al.,  1992), and cardiac myocytes (Slot et al., 
1991b).  Except for GLUT4, all quantitation was done using 
the species-specific monoclonal antibody 37.6, which recog- 
nizes  only the exogenous transporter.  Independent clonal 
cell lines were studied to eliminate clonal variability as a 
possible explanation for the results and to exclude the possi- 
bility of systematic error.  Under basal conditions, plasma 
membrane  staining  accounted  for  approximately  half of 
GLUTI but only about 5 % of GLUT4 (Table I). Treatment 
with insulin did not affect the basal GLUT1 labeling pattern 
but  caused  a  3.7-6.1-fold  increase  in  the  proportion  of 
GLUT4  in  the  plasma  membrane.  The  chimera  14-450 
(junction H), which contains only the COOH-terminus of 
GLUT4, was just as effectively sequestered within the cell 
as GLUT4, showing only ~5 % of the signal in the plasma 
membrane. After treatment with insulin, the proportion of 
the labeling in the plasma membrane increased by 6.8-10.5- 
fold. Fig.  12 shows an example of the labeling pattern ob- 
served for 14-450 in the presence and absence of  insulin. The 
pattern of its staining was very similar to that of GLUT4 un- 
der both conditions. The chimera 41-24 (junction A), which 
contains only the NH2 terminus of GLUT4, targeted simi- 
larly to GLUT1. The chimera 414-440,491, which paradoxi- 
cally exhibited intracellular targeting, showed a result inter- 
mediate between GLUT1 and GLUT4, with 14.5-19.7% of 
the labeling in the plasma membrane. However, no redistri- 
bution of the labeling occurred in response to insulin. Thus, 
this chimera appears to be targeted to intracellular compart- 
ments that are not insulin responsive. 
The function of chimeric glucose transporters was exam- 
ined by measurement of  basal and insulin-stimulated 2-deoxy- 
glucose uptake in clonal cell lines expressing them. Interpre- 
tation  of these  data  is  hindered  by  the  heterogeneity of 
endogenous GLUTI  and GLUT3 expression in the clonal 
lines and by the heterogeneity of expression of the chimeras 
themselves. Nevertheless, three conclusions can be drawn 
from the results shown in Table II. First, overexpression of 
GLUT1 and of the chimera containing only the NH2 termi- 
nus of GLUT4, 41-24 (junction A), elevated basal glucose 
transporter activity, as would be expected for transporters 
targeted to the plasma membrane. Second, most cell lines 
exhibited the degree of insulin responsiveness characteristic 
of L6 myoblasts, that is, about a  1.3- to 1.5-fold stimulation 
of 2-deoxyglucose uptake. In contast to the report of Robin- 
son et al. (1993), L6 cells expressing GLUT4 did not show 
an increase in insulin responsiveness. It is important to note 
that the L6 cells studied by Robinson et al. (1993) were actu- 
ally a subclone of L6 cells, which they acknowledged behaved 
abnormally and did not express glucose transporters in a pat- 
tern consistent with previous studies of L6 cells. The L6 sub- 
clone studied by Robinson et al. (1993) expressed extremely 
low levels of endogenous GLUT1 and GLUT3 compared to 
other reports (Bilan et al., 1992; Mitsumoto and Klip, 1992) 
and to the cells we studied. Robinson et al. also expressed 
GLUT4 at up to 30-fold higher levels than in untransfected 
cells, while expression 0f GLUT4 in the cells we studied was 
limited to eightfold above the level in untransfected cells. In 
other words,  GLUT4 was the predominant glucose trans- 
porter in the cells of Robinson et al., but only a minor glu- 
cose tranporter in the cells we studied. However, the cell line 
Halley et al. Insulin-sensitive Targeting of GLUT4  651 Figure 10. Ultrastructural localization of GLUT1 in transfected  L6 myoblasts.  Frozen thin sections of L6 myoblasts  overexpressing  GLUT1 
were stained with F350, followed  by goat anti-rabbit IgG complexed  to 18-nm gold particles. Cells are shown under basal conditions (A) 
and after exposure to insulin (B) as described in Materials and Methods. Under both conditions, GLUT1 is enriched in plasma membrane 
domains, especially microvilli. PM, plasma membrane; ME, microvilli. Bar, 175 nm. 
expressing the chimera containing only the COOH terminus 
of GLUT4, 14-450 (junction H), responded to insulin with 
a 2.7-fold increase in transport activity. Detection of insulin 
responsiveness by measurement of 2-deoxyglucose uptake 
in these cells was possible because, compared to the ceils we 
studied that overexpressed GLUT4, cells expressing 14-450 
contain 60%  less GLUT1, 20%  less GLUT3, and express 
three times as much of a glucose transporter that appears to 
translocate more efficiently than GLUT4 itself. Expression 
of this chimera did not appreciably alter basal 2-deoxyglu- 
cose uptake. Finally, the cells expressing the chimera which 
exhibited paradoxical intracellular targeting, 414-440,491 
(junctions G and K), exhibited no insulin responsiveness, but 
showed very high basal 2-deoxyglucose uptake.  This was 
most likely due to the high levels of expression of endoge- 
nous GLUT1  and GLUT3 in this cell line. 
Discussion 
As reviewed in the introduction, several groups have studied 
GLUT4 targeting domains in insulin-insensitive cells and 
have reported contradictory results. There are several  pos- 
sible  explanations  for  discrepancies  in  identification  of 
GLUT4 targeting domains. The finding that transgenic mice 
overexpressing GLUT4 in fat (Shepherd et al.,  1993) and 
muscle (Liu et al.,  1993) do demonstrate changes in basal 
as well as insulin-stimulated glucose uptake raises the possi- 
bility that certain levels of expression of GLUT4 saturate the 
machinery responsible for its accurate sorting and intracellu- 
lar  sequestration.  In the  study of Piper  et al.  (1992),  as 
pointed out previously (Asano et al., 1992),  chimeric trans- 
porters were expressed at twice the level of expression of 
GLUT4  in  3T3-L1  adipocytes.  Furthermore,  this  was 
achieved by lethally infecting cells with recombinant Sindbis 
virus and subsequently treating the cells with cycloheximide. 
Asano et al. (1992) and Czech et al. (1993) have commented 
on the potential problems with this method. To test the valid- 
ity of this approach, we carried out preliminary experiments 
using recombinant Vaccinia virus, which also lethally infects 
cells and causes high levels of expression of exogenous pro- 
teins. We performed these experiments in several  different 
cell types, including L6 myoblasts, 3T3-L1 fibroblasts and 
adipocytes, raft fibroblasts, and CV1 cells. We achieved high 
levels of expression in all cell types, and noted both GLUT1 
and GLUT4 to be distributed both to the plasma membrane 
and to intracellular compartments (data not shown). Target- 
ing patterns varied according to the time elapsed after infec- 
tion,  and the reproducibility was poor.  We speculate that 
specific sorting mechanisms are saturated and overwhelmed 
at the levels of expression of chimeric transporters caused by 
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calization of GLUT4 in trans- 
letted  L6  myoblasts.  Frozen 
thin sections of L6 myoblasts 
overexpressing GLUT4  were 
stained  with  F349,  followed 
by goat anti-rabbit IgG com- 
plexes  to  18-rim  gold  parti- 
cles.  Cells are  shown  under 
basal  conditions  (A  and  B) 
and after exposure to insulin 
(C) as described in Materials 
and  Methods.  Staining  of 
GLUT4 in basal cells is con- 
centrated  in  endosome-like 
compartments  and tubulovesic- 
ular structures, often in close 
proximity to Golgi stacks (A). 
GLUT4 labeling of the plasma 
membrane is minimal in basal 
cells (B). The GLUT4 label- 
ing of the plasma membrane 
increased  after  insulin treat- 
ment (C). PM, plasma mem- 
brane; MV, microvilli; TE, tu- 
bulo-vesicular  elements;  E, 
endosome-like compartment; 
G, Golgi. Bar,  175 rim. 
Haney et al. Insulin-sensitive Targeting of GLUT4  653 Table I. Distribution  of Wild-type and Chimeric Glucose Transporters in L6 Myoblasts 
Proportional  distribution 
Expressed protein  Clonal line  Condition  Plasma membrane  Intracellular  Particles per cell 
GLUTI  61  Basal  51.4  ±  1.6  48.6  +  1,6  24,8  +  3.1 
Insulin  55.2  ±  0.8  44.8  ±  0,8  46.7  ±  3.6 
67  Basal  53.1  ±  1.6  46.9  +  1.6  21.5  ±  2.1 
Insulin  56.9 ± 5.3  43.1  + 5.3  22.4 ± 3.1 
GLUT4  35  Basal  6.1  ±  1.0  93.9 +  1.0  27.7 + 2.5 
Insulin  24.4 ± 2.7  76.6 + 2.7  31.2 5- 2.7 
44  Basal  5.2 ±  1.3  94.8 ±  1.3  22.9 + 6.9 
Insulin  19.3 ±  1.8  80.7 ±  1.8  49.6 ± 5.8 
83  Basal  4.2 ±  1.1  95.8 ±  1.1  38.3 ±  3.4 
Insulin  25.5 ± 2.0  74.5 + 2.0  37.7 + 2.8 
14-450  36  Basal  5.2  ± 0.9  94.8 ± 0.9  31.6 +  3.8 
Insulin  35.2 ± 2.9  64.8 + 2.9  28.7 ± 2.8 
63  Basal  4.6 ±  1.8  95.4 ±  1.8  32.5 ±  3.0 
Insulin  48.5:1:1.4  51.5 ±  1.4  51.8 ± 6.1 
93  Basal  4.8 ±  1.1  95.2 ±  1.1  27.6 ± 2.0 
Insulin  41.7 ± 2.7  58.3 ± 2.7  23.5 :t: 1.8 
41-24  36  Basal  60.1 5:1.5  39.9 +  1.5  26.2 + 2.3 
Insulin  56.1  ±  1.1  43.9 +  1.1  34.7 ± 2.6 
414-440,491  51  Basal  14.5 ± 0.9  85.5 ± 0.9  50.6 ±  6.3 
Insulin  13.4 +  1.1  86.6 +  1.1  60.6 ±  3.7 
71  Basal  19.7 ±  1.1  80.3 +  1.1  38.6 + 2.8 
Insulin  17.9 ±  1.2  82.1  ±  1.2  42.0 ± 2.4 
Ultra-thin cryosections  of transfected  I_,6 myoblast lines were prepared,  stained by indirect immunogold labeling,  and analyzed as described  in Materials and 
Methods. The species-specific monoclonal antibody 37.6 was used for quantitation in all cases except for ceils overexpressing GLUT4,  which were quantitated 
using F349. Results are shown as means +  SEM for 10 ceils per condition per clonal line. Untransfected cells showed a range of 0 to 4 particles per cell, primarily 
within the nucleus. Particles staining the nucleus constituted no more than 15 % of the staining in transfected calls and were not included in calculations of propor- 
tional distribution.  For certain clones, apparent differences in particles per cell between basal and insulin-stimulated states may not be meaningful because the 
two conditions were not studied side by side. These include: GLUT1,  clone 61; GLUT4, clone 44;  14-450, clone 63; 41-24, clone 36; and 414-440,491,  clone 
51.  The remaining clones were studied side by side. 
recombinant Sindbis virus and Vaccinia virus. Therefore, we 
studied chimeras expressed  in stably transfected L6 cells. 
The CMV-based expression vector we used resulted in ex- 
pressin of heterologous transporters at no higher an abun- 
dance than that of endogenous transporters, addressing con- 
cerns related to saturation of  a cellular targeting mechanism. 
This permitted examination of the subcellular distribution of 
chimeras expressed in a steady-state at relatively low levels. 
We and others consider this condition an absolute prerequi- 
site for valid targeting studies; Czech et al (1993) offered a 
model for GLUT4 targeting in which the specific GLUT4 
targeting mechanism was saturated in the range of total en- 
dogenous transporter  expression.  One unavoidable conse- 
quence of our approach, especially considering the levels of 
GLUT1 (Mitsumoto and Klip,  1992) and GLUT3 (Bilan  et 
al., 1992) expression in L6 cells, is that the expression of rel- 
atively low levels of heterologous transporters can not be ex- 
pected to result in several-fold changes in total cellular glu- 
cose uptake. Certain subclonal L6 cell lines overexpressing 
GLUT4 (Lawrence et al.,  1992; Robinson et al.,  1993) con- 
tain much less GLUT1 and GLUT3 than unselected L6 cells 
and are capable of exhibiting a  several-fold stimulation of 
glucose uptake in response to insulin.  However,  in the cells 
we studied, which show abundant expression of GLUT1 and 
GLUT3, subcellular targeting behavior can not be inferred 
from changes in glucose transport activity alone. 
A further complication in interpreting the study of Piper 
et al. (1992) is that the chimeras used to demonstate intracel- 
lular targeting presumably conferred by the NH2 terminus 
also contained that portion of the COOH terminus which 
others have shown is important in intracellular sequestration 
(Czech et al.,  1993;  Marshall et al.,  1993a; Verhey et al., 
1993; this study). It is especially puzzling that Piper et al. 
did not detect the intracellular sequestration caused by the 
COOH terminus in either their original report (1992) or in 
a subsequent study (Piper et al.,  1993a) attempting to define 
the NH2-terminal  targeting motif. 
Immunocytochemical  data from confocal immunofluores- 
cence microscopy (Fig. 9) and immunogold electron micros- 
copy (Table I), as well as 2-deoxyglucose uptake (Table II), 
demonstrate that the NH2 terminus of GLUT4 has no dis- 
cernible intracellular targeting activity in L6 myoblasts.  Fig. 
9 also shows that a chimera similar to the constructs used 
by Piper et al. (1992),  414-24, 467, does indeed display in- 
tracellular targeting, but this is attributable to its COOH ter- 
minus, not its NH2 terminus.  Garippa et al.  (1994)  suggest 
that the NH2 terminus of GLUT4 does not function as an 
intracellular retention signal but rather contains an internal- 
ization motif. However, chimeras of this motif and the trans- 
ferrin receptor show a •50%  localization at the cell surface 
(Garippa et all,  1994).  These results clearly rule out an im- 
portant role for this motif in causing the virtual exclusion of 
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calization  of  14-450  (junc- 
tion  H),  which  contains  the 
COOH-terminal  cytoplasmic 
tail of GLUT4, in transfected 
L6 myoblasts. Its staining pat- 
tern was very similar  to that of 
GLUT4  (see  Fig.  11). Cells 
are shown under basal condi- 
tions (A and B) and after ex- 
posure to  insulin (C)  as de- 
scribed  in  Materials  and 
Methods,  stained with F349. 
The plasma membrane label- 
ing increased by 6.8-10.5-fold 
after  insulin  treatment.  PM, 
plasma  membrane;  M~,  mi- 
crovilli;  TE,  tubulovesicular 
elements;  E,  endosome-like 
compartment; G, Golgi. Bar, 
175 nm. 
Haney et al. Insulin-sensitive Targeting of GLUT4  655 Table II. 2-Deoxyglucose Uptake of L6 Myoblasts Expressing Wild-type and Chimeric Glucose Transporters 
Endogenous  Endogenous  Total  Heterologous  Basal  Insulin-stimulated  Insulin- 
GLUT1  GLUT3  GLUT4  transporter  2-DOG uptake  2-DOG uptake  responsiveness 
ng/20 I~g  L6 =  1.0  ng/20 ttg  ng/20 g.g  pmol/mg/min  pmol/mg/min  fold 
L6  6.8  1.0  0.2  0  124  -I-  12  170  -I- 22  1.4 
GLUT1  4.3  0.8  0.2  13.1  232  5:42  303  +  21  1.3 
GLUT4  9.2  1.5  1.6  nd  144  +  8  205  +  12  1.4 
14-450  3.8  1.2  0.5  5.0  146  5:6  400:1:82  2.7 
41-24  8.5  1.5  0,6  5.2  198  +  29  306  +  29  1.5 
414-440,491  20.2  2.5  0.5  3.3  296  +  42  294:1:38  1.0 
The content of endogenous and exogenous transporters was determined by densitometric analysis of Western blots as described in Materials and Methods. The 
content of the heterologously expressed chimeric transporters was measured using the species-specific  monoclonal antibody 37.6. Polyclonal  antibodies against 
the COOH termini of GLUT1 and GLUT4 recognized both endogenous and chimeric transporters. For the cell lines expressing GLUTI and 41-24, the content 
of endogenous GLUTI was calculated by subtracting the content of the chimeric transporter from the transporters recognized by the polyclonal antibody F350. 
For cell lines expressing GLUT4, 14-450,  and 414-440,491, the total GLUT4 content was calculated by subtracting the content of the chimeric transporter from 
the transporters recognized by the polyclonal antibody F349. GLUT4 does not contain the epitope recognized by the monoclonal antibody, so that a value for 
the heterologous transporter content cannot be determined (rid, not determined). The GLUT3 content is expressed relative to the GLUT3 content of untransfeeted 
cells. 2-Deoxyglucose  uptake was measured as described in Materials and Methods. Cells were rinsed and maintained in serum-free medium for 2 h before determi- 
nation of uptake over a 6-rain period. Insulin treatment was for 20 rain at 10  -s M. Results are shown as means :t: SEM of six determinations and are corrected 
for non-carder-mediated uptake as determined in the presence of 20 t~M cytochalasin B. 
GLUT4 from the plasma membrane of adipocytes and mus- 
cle cells. Neither our data (Marshall et al., 1993a;  this re- 
port) nor those published by other investigators (Asano et 
al., 1992; Czech et al., 1993; Verhey et al., 1993, 1994) sup- 
port  the hypothesis of Piper et al.  (1992,  1993) that the 
NH2-terminal  cytoplasmic tail of GLUT4 is important in 
determining its steady-state distribution. 
Three of the previous studies of GLUT4 targeting domains 
in non-insulin-sensitive ceils indicate that intracellular lo- 
calization is a function not only of the COOH-terminal cy- 
toplasmic tail but also a  weaker determinant in the NH2- 
terminal  half of GLUT4  exclusive of the  NH2  terminus 
(Verhey et al.,  1993;  Czech et al.,  1993;  Marshall et al., 
1993a). A targeting domain between amino acids 53 and 132 
would be consistent with all three studies, as well as with 
one of the two signals identified by Asano et al.  (1992). 
Nevertheless, in L6 cells, chimeras containing this region of 
GLUT4, but not the COOH-terminus, show targeting that 
appears to be very similar to GLUT1. Marshall et al. (1993a) 
presented evidence that chimeras containing this region of 
GLUT4 might be poorly transported beyond the endoplas- 
mic reticulum in Xenopus oocytes. One possible explanation 
for this apparent discrepancy is that L6 cells may contain 
cell-type specific chaperone proteins that facilitate matura- 
tion  of  chimeric  transporters  containing  this  region  of 
GLUT4. Intracellular targeting attributed to this region in 
studies of insulin-insensitive cells may reflect lack of such a 
chaperone protein. 
We identified the region between amino acids 485 and 490 
of GLUT4,  RTPSLL, as  necessary but not sufficient for 
GLUT4 targeting. This region is of interest not only because 
it contains a dileucine motif which is itself necessary for 
GLUT4 targeting (Verhey and Birnbaum, 1994), but also be- 
cause it contains ser-488,  the only known phosphorylation 
site of GLUT4 (Lawrence et al.,  1990).  This suggests the 
possibility that hormonally mediated protein phosphoryla- 
tion-dephosphorylation plays a role in regulating the intra- 
cellular targeting activity of the domain. GLUT1  contains 
neither the dileucine motif nor an analogous phosphorylation 
site. Evidence from L6 cells suggests that cAMP specifically 
inhibits glucose transport mediated by GLUT4 but not by 
GLUT1 (Lawrence et al., 1992). Phosphorylation of ser-488 
may reduce GLUT4 exocytosis, increase GLUT4 endocyto- 
sis, or redirect its intracellular trafficking. However, the rela- 
tionship between GLUT4 phosphorylation and function is 
unclear (Nishimura et al., 1991; Piper et al., 1993b) and fur- 
ther experiments are necessary to examine this question. 
Our data indicate that the final 25 amino acids of GLUT4 
are necessary and sufficient to confer intracellular targeting. 
It remains to be determined whether there is more than one 
motif contained in this sequence. The COOH-terminal tail 
of the mannose-6-phosphate receptor contains two indepen- 
dent sorting motifs. One is a tyrosine-containing internaliza- 
tion signal required for rapid endocytosis from the plasma 
membrane via clathrin-coated pits. The second, the COOH- 
terminal four amino acids, includes a dileucine motif, and 
is required for efficient interaction with the Golgi adaptors 
(Johnson and Kornfeld, 1992b).  The T cell antigen receptor 
gamma chain also contains two distinct sequences  in  its 
COOH-terminal cytoplasmic tail, a tyrosine-containing mo- 
tif and a dileucine-containing motif  required for appropriate 
intracellular targeting to lysosomes (Letourneur and Klaus- 
ner, 1992). The dileucine motif has also been implicated in 
the intracellular targeting via Golgi to lysosomes of LIMP 
II, a lysosomal membrane protein (Vega et al., 1991; Ogata 
and Fukuda, 1994; Sandoval et al., 1994), the cation-depen- 
dent mannose-6-phosphate receptor (Johnson and Kornfeld, 
1992a),  and CD4,  the main HIV  receptor (Aiken et al., 
1994).  Verhey and Birnbaum (1994) have reported that the 
dileucine motif is required for GLUT4 targeting in fibro- 
blasts; their cogent argument that GLUT4, not GLUT1, is 
the actively targeted transporter, and that the dileucines con- 
stitute an essential part of the GLUT4 COOH-terminal tar- 
geting motif, is supported by our findings in insulin-sensi- 
tive cells. 
The steady state distribution of GLUT4 in the presence of 
insulin included  19.3-25.5%  in the plasma membrane,  a 
3.7-6.1-fold enrichment compared to basal conditions. Of 
note, in the presence of insulin, the steady state distribution 
of the chimera  14-450, which contains only the  COOH- 
terminal cytoplasmic tail of GLUT4, included 35.2-48.5 % 
in the plasma membrane, a 6.8-10.5-fold  enrichment com- 
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spond to insulin better than GLUT4 itself does.  Since the 
steady state distribution reflects a balance between exocyto- 
sis and endocytosis, this suggests that, in the presence of in- 
sulin but not under basal conditions, the chimera 14-450 is 
either exocytosed more rapidly, endocytosed more slowly, or 
both.  Our experimental approach does not distinguish be- 
tween these mechanisms. 
There is evidence that GLUT1  may oligomerize (Pessino 
et al.,  1991),  and that oligomerization may have important 
functional  consequences  (Hebert  and  Carruthers,  1992). 
This potential complication must be taken into account in in- 
terpretation  of  the  targeting  of  chimeric  glucose  trans- 
porters. The area identified by this approach might theoreti- 
cally represent  not a targeting  domain itself, but an area of 
the chimera that  causes  oligomerization with endogenous 
GLUT4, which contains the actual domains responsible for 
the intracellular  targeting.  Oligomerization of chimeras with 
endogenous GLUT1 or GLUT3 would presumably not cause 
misidentification  of an intracellular targeting  motif,  since 
these transporters are not sequestered within the cell. Oligo- 
merization is itself a potential mechanism for retention of 
Golgi-resident proteins (Weisz et al., 1993). The distinct tar- 
geting patterns of GLUT1 and GLUT4 suggest that there is 
no interaction  between these two isoforms. Coimmunopre- 
cipitation experiments have shown that GLUT1 and GLUT4 
do not interact, but that GLUT1 forms homo-oligomers (Pes- 
sino et al.,  1991).  Oligomerization of GLUT4 segments of 
chimeras with endogenous GLUT4 is not a plausible expla- 
nation  for the intracellular targeting  observed in our study. 
The cell lines expressing the chimera 14-450 contain at least 
ten times as much chimera as they do endogenous GLUT4. 
Therefore, it would be stoichiometrically impossible to at- 
tribute  the intracellular  targeting  of this chimera to an as- 
sociation with endogenous GLUT4. 
The  high  degree  of homology  (65 % identity  and  76 % 
similarity) between GLUT1 and GLUT4 make the study  of 
chimeric  glucose  transporters  especially  attractive.  How- 
ever,  the  aberrant  intracellular  targeting  of 414-440,  491, 
and, presumably,  of 41-479 (junction I) and 41-490 (junction 
K), amplifies the questions raised by Low et al. (1994) con- 
cerning the validity of using intracellular sequestration alone 
as an assay  for specific targeting  signals.  Studies should be 
designed  to  examine  redundant  chimeras  and  converse 
chimeras; these offer protection against  misidentifying tar- 
geting  information.  Specifically  with  respect  to  glucose 
transporters,  a method that examines the insulin responsive- 
ness  of putative  targeting  domains  is  required  to exclude 
aberrant targeting.  In general, methods to establish not only 
the structural but also the physiological properties of a par- 
ticular compartment should be required to establish the va- 
lidity of putative targeting  signals. 
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